Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 1, 2022
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
Yatin Suneja Upgraded (ANAB) to Strong Buy on, Nov 1st, 2022
Yatin Suneja of Guggenheim, Upgraded "AnaptysBio, Inc." (ANAB) to Strong Buy on, Nov 1st, 2022.
Yatin has made no other calls on ANAB in the last 4 months.
There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 1 agrees with Yatin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Lee of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Tuesday, September 13th, 2022
These are the ratings of the 2 analyists that currently disagree with Yatin
- Gobind Singh of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Monday, September 19th, 2022
- Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $35 on, Thursday, September 1st, 2022
